The american joint committee on cancer

The 7th edition of the AJCC cancer staging manual and the future of TNM

Stephen B. Edge, Carolyn Compton

Research output: Contribution to journalArticle

3945 Citations (Scopus)

Abstract

The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

Original languageEnglish (US)
Pages (from-to)1471-1474
Number of pages4
JournalAnnals of Surgical Oncology
Volume17
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Neoplasm Staging
Neoplasm Metastasis
Neoplasms
Nomograms
Registries

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

The american joint committee on cancer : The 7th edition of the AJCC cancer staging manual and the future of TNM. / Edge, Stephen B.; Compton, Carolyn.

In: Annals of Surgical Oncology, Vol. 17, No. 6, 06.2010, p. 1471-1474.

Research output: Contribution to journalArticle

@article{5dde046cf06f46e3b828f22c489f4bc1,
title = "The american joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM",
abstract = "The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.",
author = "Edge, {Stephen B.} and Carolyn Compton",
year = "2010",
month = "6",
doi = "10.1245/s10434-010-0985-4",
language = "English (US)",
volume = "17",
pages = "1471--1474",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - The american joint committee on cancer

T2 - The 7th edition of the AJCC cancer staging manual and the future of TNM

AU - Edge, Stephen B.

AU - Compton, Carolyn

PY - 2010/6

Y1 - 2010/6

N2 - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

AB - The American Joint Committee on Cancer and the International Union for Cancer Control update the tumor-node-metastasis (TNM) cancer staging system periodically. The most recent revision is the 7th edition, effective for cancers diagnosed on or after January 1, 2010. This editorial summarizes the background of the current revision and outlines the major issues revised. Most notable are the marked increase in the use of international datasets for more highly evidenced-based changes in staging, and the enhanced use of nonanatomic prognostic factors in defining the stage grouping. The future of cancer staging lies in the use of enhanced registry data standards to support personalization of cancer care through cancer outcome prediction models and nomograms.

UR - http://www.scopus.com/inward/record.url?scp=77954818058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954818058&partnerID=8YFLogxK

U2 - 10.1245/s10434-010-0985-4

DO - 10.1245/s10434-010-0985-4

M3 - Article

VL - 17

SP - 1471

EP - 1474

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 6

ER -